Clinical Trial Update: Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 study evaluating tacrolimus ointment for chronic allergic contact dermatitis has completed and reports safety and efficacy findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Contact Dermatitis

Drugs mentioned

• Tacrolimus ointment (tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Dermatitis | Phase 4 | Status: COMPLETED